PF-05089771 is a selective blocker of the Nav1.7 sodium channel, a key target in pain signal transmission. It is mainly investigated for treating neuropathic pain conditions including trigeminal neuralgia and erythromelalgia. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include 4-[2-(5-amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-(1, 3-thiazol-4-yl)benzenesulfonamide, Benzenesulfonamide and 4-[2-(3-amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-4-thiazolyl-. Its PubChem CID is 46840946.
Pf-05089771
| CAS No | 1235403-62-9 |
|---|---|
| Molecular Formula | C18H12Cl2FN5O3S2 |
| Molecular Weight | 500.4 g/mol |
| Synonyms | 4-[2-(5-amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-(1,3-thiazol-4-yl)benzenesulfonamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
7 sodium channel, a key target in pain signal transmission. It is mainly investigated for treating neuropathic pain conditions including trigeminal neuralgia and erythromelalgia.
The listed CAS number is 1235403-62-9.
The listed molecular formula is C18H12Cl2FN5O3S2.
The listed molecular weight is 500.4 g/mol.
4-[2-(5-amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-(1,3-thiazol-4-yl)benzenesulfonamide.
The source lists 4-[2-(5-amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-(1, 3-thiazol-4-yl)benzenesulfonamide, Benzenesulfonamide and 4-[2-(3-amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-4-thiazolyl-.